The novel bacteriocin romsacin from Staphylococcus haemolyticus inhibits Gram-positive WHO priority pathogens

The novel bacteriocin romsacin from Staphylococcus haemolyticus inhibits Gram-positive WHO priority pathogens

ABSTRACT Staphylococcus haemolyticus is an increasingly relevant nosocomial pathogen. The combination of multi-drug resistance and ability to form biofilms makes S. haemolyticus infections difficult to treat. Bacteriocins are ribosomally synthesized antimicrobial peptides produced by bacteria to inh...

Full description

Bibliographic Details
Main Authors: Runa Wolden, Kirill V. Ovchinnikov, Hermoine J. Venter, Thomas F. Oftedal, Dzung B. Diep, Jorunn Pauline Cavanagh
Format: Article
Language:English
Published: American Society for Microbiology 2023-12-01
Series:Microbiology Spectrum
Subjects:
Staphylococcus haemolyticus
bacteriocin
antimicrobial resistance
biofilm
AMR
lanthipeptides
Online Access:https://journals.asm.org/doi/10.1128/spectrum.00869-23

Internet

https://journals.asm.org/doi/10.1128/spectrum.00869-23

Similar Items